Anpario (LON:ANP) Price Target Raised to GBX 600 at Canaccord Genuity Group

Anpario (LON:ANP) had its price target raised by research analysts at Canaccord Genuity Group from GBX 570 to GBX 600 in a note issued to investors on Friday, London Stock Exchange reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target indicates a potential upside of 31.84% from the company’s previous close.

Separately, Shore Capital Group restated a “house stock” rating on shares of Anpario in a research report on Monday, August 17th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Anpario has a consensus rating of “Buy” and an average price target of GBX 600.

Anpario Stock Performance

Shares of ANP stock opened at GBX 455.10 on Friday. The company has a market capitalization of £74.12 million, a P/E ratio of 12.00 and a beta of 1.08. Anpario has a fifty-two week low of GBX 391.11 and a fifty-two week high of GBX 580. The company has a debt-to-equity ratio of 0.60, a quick ratio of 5.16 and a current ratio of 6.29. The stock has a 50 day moving average price of GBX 529.75 and a two-hundred day moving average price of GBX 516.08.

Anpario (LON:ANP) last issued its earnings results on Wednesday, September 9th. The company reported GBX 22.45 earnings per share (EPS) for the quarter. Anpario had a net margin of 14.53% and a return on equity of 17.05%. Analysts expect that Anpario will post 23.5757801 earnings per share for the current year.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.